Basic Information
Basic information for AL132712.2-202-45aa
Peptide Name AL132712.2-202-45aa
Genome Position chr14:103873380-103873461,103877395-103877447[+]
Species Human
Peptide Sequence MISAHCNLHLPGSSDSPGSASGVAGITVFLPRVSPRAASFDSCCV
Peptide Length 45
Unique Yes
Grand Average of Hydropathicity 0.4311
Relative Molecular Mass 5295.78
Experimental Evidences 1:IRES
lncRNA ID/Name ENSG00000287346;AL132712.2
Transcript ID/Name ENST00000667526;AL132712.2-202
Transcript Length 1473
Coding Ability 0.5316
DNA Sequence Corresponding to Peptide ATGATCTCGGCTCACTGCAACCTCCACCTCCCAGGGTCAAGTGATTCTCCTGGGTCAGCCTCCGGAGTAGCTGGGATTACAGTTTTTCTTCCCAGGGTCTCCCCAAGAGCTGCTTCCTTTGACTCCTGCTGTGTG
Experimental Evidences
   IRES
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :